Innovative Alliance Setting New Standards in Calibration Technology
International Isotopes Inc. (INIS) and Phantech Medical have teamed up to launch an exciting new joint venture called PhanQual. This collaboration is set to transform the field of pre-clinical imaging by developing cutting-edge calibration and reference sources. With a strong emphasis on innovation in the medical imaging sector, this partnership promises to provide significant benefits to researchers and healthcare professionals around the globe.
Understanding Phantech's Role in Medical Imaging
Located in the heart of the United States, Phantech Medical focuses on biomedical hardware, specifically aimed at enhancing pre-clinical imaging capabilities. Their dedication to innovation shines through in the advanced phantom technologies they have developed, which play a crucial role in improving the accuracy and efficiency of quality management in medical imaging. As the industry shifts towards more reliable methods, Phantech's expertise becomes increasingly vital.
International Isotopes Inc. and Its Legacy
Since its founding in 1995, International Isotopes Inc. has led the way in producing a diverse array of radioisotope-based products, including calibration solutions for nuclear pharmacies and imaging systems. Their extensive experience, particularly through their wholly owned subsidiary RadQual, has established them as leaders in providing sealed calibration sources. This collaboration with Phantech is a continuation of their commitment to enhancing healthcare through state-of-the-art technology.
The Vision Behind PhanQual
PhanQual embodies a strategic initiative that combines the technical resources, facilities, and expertise of both companies. By integrating Phantech's innovative fillable calibration source technology into sealed source devices, this venture aims to advance research and development in nuclear medicine and theranostics. This partnership goes beyond simply merging capabilities; it seeks to broaden the reach of groundbreaking solutions in the global market.
Voices from Leadership: Insights on the Partnership
Justin Jeffery, Co-Founder and Head of R&D at Phantech, expressed his excitement about the partnership, noting the extensive industry experience that INIS contributes. He highlighted the shared objective of both companies: to enhance accuracy in nuclear medicine imaging. Similarly, Shahe Bagerdjian, President of International Isotopes, remarked on Phantech's exceptional ability to produce next-generation fillable sources, creating a synergy that fosters innovation.
A Glimpse into Future Innovations
In line with their dedication to advancing the field, both companies plan to integrate additive manufacturing and artificial intelligence into their calibration devices. This forward-thinking strategy aims to assist researchers in their vital work, ultimately saving lives through more efficient imaging solutions. The PhanQual initiative represents not just an advancement but a reimagining of how calibration sources will adapt to the needs of contemporary medical imaging.
Learn More About PhanQual
If you're interested in discovering more about PhanQual's innovations, we encourage you to reach out to the companies directly. Both International Isotopes and Phantech are eager to share insights and respond to any inquiries regarding their new offerings.
Frequently Asked Questions
What is PhanQual?
PhanQual is a joint venture between International Isotopes Inc. and Phantech Medical focused on developing calibration sources for pre-clinical imaging.
What technologies will PhanQual utilize?
PhanQual will leverage patented fillable calibration source technology and the facilities and expertise of both INIS and Phantech.
How does this partnership benefit medical researchers?
This collaboration aims to enhance the accuracy and availability of calibration sources, helping researchers conduct their work more effectively.
What makes Phantech unique in the field of medical imaging?
Phantech is known for its innovative phantom technologies that improve quality management processes in medical imaging.
How long has International Isotopes Inc. been in operation?
International Isotopes Inc. has been operational since 1995, with over 25 years of experience in producing radioisotope-focused products.
